1. Home
  2. CZWI vs TNXP Comparison

CZWI vs TNXP Comparison

Compare CZWI & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CZWI
  • TNXP
  • Stock Information
  • Founded
  • CZWI 1938
  • TNXP 2007
  • Country
  • CZWI United States
  • TNXP United States
  • Employees
  • CZWI N/A
  • TNXP N/A
  • Industry
  • CZWI Savings Institutions
  • TNXP Biotechnology: Pharmaceutical Preparations
  • Sector
  • CZWI Finance
  • TNXP Health Care
  • Exchange
  • CZWI Nasdaq
  • TNXP Nasdaq
  • Market Cap
  • CZWI 132.7M
  • TNXP 118.2M
  • IPO Year
  • CZWI N/A
  • TNXP N/A
  • Fundamental
  • Price
  • CZWI $14.83
  • TNXP $18.83
  • Analyst Decision
  • CZWI
  • TNXP Strong Buy
  • Analyst Count
  • CZWI 0
  • TNXP 2
  • Target Price
  • CZWI N/A
  • TNXP $585.00
  • AVG Volume (30 Days)
  • CZWI 18.4K
  • TNXP 573.9K
  • Earning Date
  • CZWI 04-28-2025
  • TNXP 05-20-2025
  • Dividend Yield
  • CZWI 2.42%
  • TNXP N/A
  • EPS Growth
  • CZWI N/A
  • TNXP N/A
  • EPS
  • CZWI 1.27
  • TNXP N/A
  • Revenue
  • CZWI $58,040,000.00
  • TNXP $10,094,000.00
  • Revenue This Year
  • CZWI N/A
  • TNXP $12.17
  • Revenue Next Year
  • CZWI $12.31
  • TNXP $789.15
  • P/E Ratio
  • CZWI $11.72
  • TNXP N/A
  • Revenue Growth
  • CZWI N/A
  • TNXP 29.94
  • 52 Week Low
  • CZWI $10.64
  • TNXP $6.76
  • 52 Week High
  • CZWI $17.04
  • TNXP $672.00
  • Technical
  • Relative Strength Index (RSI)
  • CZWI 56.78
  • TNXP 53.35
  • Support Level
  • CZWI $14.47
  • TNXP $18.55
  • Resistance Level
  • CZWI $15.18
  • TNXP $21.99
  • Average True Range (ATR)
  • CZWI 0.41
  • TNXP 1.53
  • MACD
  • CZWI 0.05
  • TNXP 0.22
  • Stochastic Oscillator
  • CZWI 59.88
  • TNXP 58.64

About CZWI Citizens Community Bancorp Inc.

Citizens Community Bancorp Inc is a bank holding company that offers traditional community banking services to businesses, Agricultural operators, and consumers, including one-to-four-family residential mortgages. it also offers a variety of loan products including commercial real estate loans, commercial and industrial (C&I) loans, agricultural real estate loans, agricultural operating loans, residential mortgages, home equity lines-of-credit, and consumer loans and offers deposit products through its branches, including demand deposits, various savings and money-market accounts and certificates of deposit. The company's sources of funds are deposits; amortization, prepayments, and maturities of outstanding loans; other short- term investments; and funds provided from operations.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

Share on Social Networks: